Log entry Nº 325 · the stack watch
Bearing SW 225° · October 30, 2026 · 3 min read
Advertising TechSW 225°Watch log
OptimizeRx Takes EHR Ads Programmatic With The Trade Desk Deal
OptimizeRx partners with The Trade Desk, taking its doctor-facing EHR ad inventory beyond pharma-focused DSP DeepIntent and opening NPI-based targeting to consumer brands.
By Tom Whitfield3 min read554 words

OptimizeRx has struck a programmatic partnership with The Trade Desk this month, moving its doctor-facing electronic health record inventory beyond the pharma-regulated DSP DeepIntent for the first time.
The company sells ad space inside HCP electronic health records (EHRs). All of its inventory sits within the doctor's log-in portal at the point of care — the moment a physician sets up a prescription or copay card for a patient — and its advertisers to date have all been pharmaceutical brands.
"We knew that we needed to enter the [programmatic] space very carefully," Maria Cipicchio, SVP of strategic market intelligence at OptimizeRx, told AdExchanger.
How did OptimizeRx get here?
The company began working with DeepIntent earlier this year on a programmatic banner ad partnership. Before that, OptimizeRx earned marketing revenue mainly from pharmaceutical brands offering financial incentives — effectively covering part of drug costs — to encourage doctors to choose their products.
Programmatic units carry new risks, Cipicchio said. Pharma marketers do not want ads placed alongside actual patient data. That is not a government requirement; it is a preference the marketers hold. OptimizeRx also vets every ad creative, she said, both to screen out inappropriate content and to ensure no ad feels errant or misleading to the physician. Each ad must stay focused on relevant healthcare data about its product.
"But the buyer doesn't ever see that aspect of it, which is one of the beauties of programmatic," Cipicchio said.
What does the targeting look like?
Targeting rests on the National Provider Identifier (NPI), a unique medical identifier assigned to every prescribing doctor. Unlike web or CTV targeting, every advertiser on OptimizeRx knows exactly who sees the ad, and the identifier persists throughout the physician's career. There are no bots. The ad is fully in view and never falls "below the fold," Cipicchio said.
Part of the appeal of the Trade Desk partnership "is the OpenPath idea," she said. Through OpenPath, the DSP could analyze ads served within the HCP EHR against campaigns running on streaming TV or other channels.
What does this change for advertisers?
A general-purpose programmatic partner like The Trade Desk opens the door to marketers beyond the prescription base. More than 99% of OptimizeRx's ad business has been tied to prescription drug brands to date, Cipicchio said — but "there's no restriction on that in the programmatic arena."
Consumer brands have an obvious use case. "Every skincare product wants a doctor to recommend their product," Cipicchio said. Doctors routinely recommend over-the-counter products such as NyQuil or Tylenol even while treating a patient over weeks or months. An over-the-counter allergy brand, for example, could use The Trade Desk's system to target geographical areas during allergy breakout seasons, such as spring pollen.
Other marketers, she said, want the chance to serve an ad to specific doctors right before a patient receives their next steps in care.
Those are the sales pitches OptimizeRx can now make. The company is taking a conservative approach to programmatic — but it sees the revenue prospects clearly enough to have made the leap from DeepIntent, a healthcare-focused DSP that lives inside the same regulatory bubble as OptimizeRx, to working with The Trade Desk as well.
The point-of-care ad space now has a general programmatic on-ramp.
Plot points
- OptimizeRx struck a programmatic partnership with The Trade Desk this month.
- More than 99% of OptimizeRx's ad business to date has been tied to prescription drug brands.
- OptimizeRx began a programmatic banner ad partnership with DeepIntent earlier this year.
- Targeting is based on the National Provider Identifier (NPI), persistent across a doctor's career.
- The Trade Desk deal opens OpenPath cross-channel analysis against streaming TV and other channels.
via AdExchanger (Source)
More from Tom Whitfield
Show full bio
News editor covering money, funding and market shifts around marketing technology at Martech Beacon.
34 articles
Neighbouring fixes
- LG Ad Solutions, Best Buy Ads Link Premium CTV to Retail Media
- Tom Schwenger Takes Charge of Omnicom Health’s Marketing Arm
- Salesforce Brings Agentforce to Life Sciences; Pfizer, Fidia Sign On
- Costco Taps Moloco to Scale Its Retail Media Network
- Zeotap launches Open CDP, the first composable lakehouse CDP